Literature DB >> 30004800

Transplantation in highly sensitized patients: challenges and recommendations.

Sebastiaan Heidt1, Frans H J Claas1.   

Abstract

INTRODUCTION: Highly sensitized patients awaiting a kidney transplant accrue on the transplant waiting list. The breadth of HLA antibodies in this subpopulation of patients precludes receiving a compatible organ offer through regular allocation within an acceptable time-frame. Areas covered: Several alternative options to receive a transplant exist for these patients, including additional priority in regular allocation, special programs based on allocation through acceptable antigens, kidney paired donation programs, desensitization protocols, or a combination of the latter two. In this review, these options and their outcomes are discussed as well as some possibilities to further enhance transplantation of this disadvantaged group of patients. Expert commentary: For highly sensitized patients, special attention is required, for which several strategies may apply. A step-wise approach may be the optimal strategy to facilitate successful transplantation of highly sensitized patients.

Entities:  

Keywords:  Highly sensitized; acceptable mismatch; desensitization; kidney paired donation; transplantation

Mesh:

Substances:

Year:  2018        PMID: 30004800     DOI: 10.1080/1744666X.2018.1498335

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  5 in total

Review 1.  Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.

Authors:  Ilse Gille; Frans H J Claas; Geert W Haasnoot; Mirjam H M Heemskerk; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Authors:  Sebastiaan Heidt; Geert W Haasnoot; Marian D Witvliet; Marissa J H van der Linden-van Oevelen; Elena G Kamburova; Bram W Wisse; Irma Joosten; Wil A Allebes; Arnold van der Meer; Luuk B Hilbrands; Marije C Baas; Eric Spierings; Cornelis E Hack; Franka E van Reekum; Arjan D van Zuilen; Marianne C Verhaar; Michiel L Bots; Adriaan C A D Drop; Loes Plaisier; Marc A J Seelen; Jan-Stephan Sanders; Bouke G Hepkema; Annechien J A Lambeck; Laura B Bungener; Caroline Roozendaal; Marcel G J Tilanus; Christina E Voorter; Lotte Wieten; Elly M van Duijnhoven; Marielle A C J Gelens; Maarten H L Christiaans; Frans J van Ittersum; Shaikh A Nurmohamed; Neubury M Lardy; Wendy Swelsen; Karlijn A M I van der Pant; Neelke C van der Weerd; Ineke J M Ten Berge; Frederike J Bemelman; Andries Hoitsma; Paul J M van der Boog; Johan W de Fijter; Michiel G H Betjes; Henny G Otten; Dave L Roelen; Frans H J Claas
Journal:  Am J Transplant       Date:  2019-07-01       Impact factor: 8.086

3.  Low incidence of IgA isotype of HLA antibodies in alloantigen exposed individuals.

Authors:  Helena Car; Gonca E Karahan; Geertje J Dreyer; Simone H Brand-Schaaf; Aiko P J de Vries; Cees van Kooten; Cynthia S M Kramer; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  HLA       Date:  2020-12-02       Impact factor: 4.513

Review 4.  HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers.

Authors:  Nizar Joher; Marie Matignon; Philippe Grimbert
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

Review 5.  Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.

Authors:  Sebastiaan Heidt; Geert W Haasnoot; Marissa J H van der Linden-van Oevelen; Frans H J Claas
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.